Lombard Odier Asset Management USA Corp trimmed its position in shares of Calumet, Inc. (NASDAQ:CLMT – Free Report) by 21.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 100,095 shares of the oil and gas company’s stock after selling 27,405 shares during the quarter. Lombard Odier Asset Management USA Corp’s holdings in Calumet were worth $1,989,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the company. Covestor Ltd grew its position in Calumet by 29.1% during the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after purchasing an additional 492 shares during the last quarter. ProShare Advisors LLC grew its position in Calumet by 6.9% during the 4th quarter. ProShare Advisors LLC now owns 12,613 shares of the oil and gas company’s stock valued at $251,000 after purchasing an additional 817 shares during the last quarter. Aster Capital Management DIFC Ltd grew its position in Calumet by 294.7% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after purchasing an additional 1,229 shares during the last quarter. Islay Capital Management LLC purchased a new stake in Calumet during the 4th quarter valued at about $25,000. Finally, Global Retirement Partners LLC purchased a new stake in Calumet during the 4th quarter valued at about $34,000. 34.41% of the stock is owned by hedge funds and other institutional investors.
Calumet Stock Down 2.2%
Shares of NASDAQ CLMT opened at $32.69 on Wednesday. The firm’s 50-day moving average price is $33.50 and its 200-day moving average price is $27.61. The company has a market cap of $2.85 billion, a PE ratio of -15.13 and a beta of 0.73. Calumet, Inc. has a 52-week low of $12.94 and a 52-week high of $38.75.
Analyst Upgrades and Downgrades
Several analysts recently commented on CLMT shares. HC Wainwright increased their price objective on shares of Calumet from $33.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, March 30th. TD Cowen reissued a “hold” rating on shares of Calumet in a research report on Wednesday, June 3rd. The Goldman Sachs Group downgraded shares of Calumet from a “buy” rating to a “neutral” rating and set a $36.00 price target on the stock. in a report on Friday, April 24th. Finally, Weiss Ratings raised shares of Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Calumet has an average rating of “Hold” and a consensus target price of $36.75.
Read Our Latest Stock Report on CLMT
Insider Transactions at Calumet
In related news, major shareholder Group Heritage sold 626,998 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $32.54, for a total value of $20,402,514.92. Following the transaction, the insider owned 12,980,211 shares of the company’s stock, valued at approximately $422,376,065.94. This trade represents a 4.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Daniel J. Sajkowski sold 3,310 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $34.46, for a total transaction of $114,062.60. Following the completion of the transaction, the director directly owned 81,958 shares in the company, valued at approximately $2,824,272.68. The trade was a 3.88% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 4.07% of the company’s stock.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Read More
- Five stocks we like better than Calumet
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding CLMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calumet, Inc. (NASDAQ:CLMT – Free Report).
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
